Biomarin Pharmaceutical Aktie
58,14
EUR
-0,04
EUR
-0,07
%
61,76
USD
-0,16
USD
-0,26
%
Biomarin Pharmaceutical Aktie Analyse
| 27.07.09 | Biomarin Pharmaceutical buy | ROTH Capital Partners, LLC | |
| 31.03.09 | Biomarin Pharmaceutical market weight | Thomas Weisel Partners LLC | |
| 27.03.09 | Biomarin Pharmaceutical neutral | Piper Jaffray & Co. | |
| 12.03.09 | Biomarin Pharmaceutical outperform | Leerink Swann LLC | |
| 12.03.09 | Biomarin Pharmaceutical buy | FTN Midwest Securities Corp. | |
| 24.02.09 | Biomarin Pharmaceutical buy | ROTH Capital Partners, LLC | |
| 23.02.09 | Biomarin Pharmaceutical buy | Jefferies & Company Inc. | |
| 19.02.09 | Biomarin Pharmaceutical neutral | Credit Suisse Group | |
|
Werbung
|
|||
| 19.02.09 | Biomarin Pharmaceutical market perform | Wachovia Securities, LLC | |
| 19.02.09 | Biomarin Pharmaceutical hold | ROTH Capital Partners, LLC | |
| 19.02.09 | Biomarin Pharmaceutical buy | Brean Murray, Carret & Co., LLC | |
| 09.01.09 | Biomarin Pharmaceutical buy | Brean Murray, Carret & Co., LLC | |
| 15.12.08 | Biomarin Pharmaceutical neutral | Credit Suisse Group | |
| 26.11.08 | Biomarin Pharmaceutical outperform | Cowen and Company, LLC | |
| 24.11.08 | Biomarin Pharmaceutical buy | Citigroup Corp. | |
| 30.10.08 | Biomarin Pharmaceutical neutral | Credit Suisse Group | |
| 30.10.08 | Biomarin Pharmaceutical buy | UBS AG | |
| 29.10.08 | Biomarin Pharmaceutical hold | ROTH Capital Partners, LLC | |
| 12.09.08 | Biomarin Pharmaceutical outperform | William Blair | |
| 27.08.08 | Biomarin Pharmaceutical outperform | Cowen and Company, LLC | |
| 22.08.08 | Biomarin Pharmaceutical hold | ROTH Capital Partners, LLC | |
| 22.08.08 | Biomarin Pharmaceutical market outperform | Rodman & Renshaw, LLC | |
| 22.08.08 | Biomarin Pharmaceutical outperform | Cowen and Company, LLC | |
| 02.07.08 | Biomarin Pharmaceutical hold | ROTH Capital Partners, LLC | |
| 12.06.08 | Biomarin Pharmaceutical hold | Citigroup Corp. | |
| 29.05.08 | Biomarin Pharmaceutical outperform | Cowen and Company, LLC | |
| 28.02.08 | Biomarin Pharmaceutical buy | Merrill Lynch & Co., Inc. | |
| 28.02.08 | Biomarin Pharmaceutical neutral | UBS AG | |
| 27.02.08 | Biomarin Pharmaceutical market outperform | Rodman & Renshaw, LLC | |
| 29.01.08 | Biomarin Pharmaceutical neutral | UBS AG | |
| 17.12.07 | Biomarin Pharmaceutical buy | Soleil Securities Group, Inc. | |
| 14.12.07 | Biomarin Pharmaceutical buy | Jefferies & Company Inc. | |
| 14.12.07 | Biomarin Pharmaceutical market outperform | Rodman & Renshaw | |
| 14.11.07 | Biomarin Pharmaceutical | Der Aktionär | |
| 05.11.07 | Biomarin Pharmaceutical buy | Ferris Baker Watts | |
| 11.10.07 | Biomarin Pharmaceutical outperform | Wachovia Sec | |
| 28.09.07 | Biomarin Pharmaceutical buy | Citigroup Corp. | |
| 25.09.07 | Biomarin Pharmaceutical market outperform | Rodman & Renshaw | |
| 27.07.07 | Biomarin Pharmaceutical buy | Ferris Baker Watts | |
| 22.03.07 | Biomarin Pharmaceutical | Der Aktionär | |
| 19.02.07 | Biomarin Pharmaceutical buy | A.G. Edwards & Sons | |
| 10.10.06 | Biomarin Pharmaceutical Buy | Am Tech/ JSA Research | |
| 08.09.06 | Biomarin Pharmaceutical neutral | Robert W. Baird | |
| 19.07.06 | Biomarin Pharmaceutical Neutral | Prudential Securities | |
| 12.06.06 | Biomarin Pharmaceutical buy | Pacific Growth Equities | |
| 04.04.06 | Biomarin Pharmaceutical | Global Biotech Investing | |
| 17.03.06 | Biomarin Pharmaceutical market outperform | Rodman & Renshaw | |
| 07.02.06 | Biomarin Pharmaceutical Market Outperform | Rodman & Renshaw | |
| 14.10.05 | Biomarin Pharmaceutical peer perform | Thomas Weisel Partners | |
| 14.10.05 | Biomarin Pharmaceutical Peer Perform | Thomas Weisel Partners | |